Fig. 3

Proportion of perfect EQ-5D-5L scorers who have experienced challenges in MIDAS items sometimes or more during the last week in the CONCARDPCI study (n = 760). ‘Major fatigue and side effects’ (Class 1) = 17%, ‘Only some fatigue and side effects’ (Class 2) = 25%, ‘Poor cardiac quality of life’ (Class 3) = 12%, and ‘Good cardiac quality of life’ (Class 4) = 46%